Global Non-Hormonal Contraception Market

Global Non-Hormonal Contraception Market Size, Share, Growth Analysis, By Gender(Male and Female), By Product type(Condoms, Diaphragms), By Distribution channel(Retail Pharmacies, Hospital Pharmacies) - Industry Forecast 2023-2030


Report ID: SQMIG35D2065 | Region: Global | Published Date: February, 2024 | Pages: 157 | Tables: 91 | Figures: 76

Global Non-Hormonal Contraception Market Insights

Non-Hormonal Contraception Market size was valued at USD 27.1 billion in 2021 and is poised to grow from USD 28.86 billion in 2022 to USD 47.77 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

Non-hormonal contraception refers to the use of birth control methods that do not contain hormones. These methods work by preventing fertilization or implantation of a fertilized egg in the uterus. There are several types of non-hormonal contraceptives available, including barrier methods, fertility awareness-based methods, and intrauterine devices (IUDs). Barrier methods of contraception include male and female condoms, diaphragms, and cervical caps. These methods create a physical barrier between the sperm and the egg, preventing fertilization from occurring. They are generally easy to use, widely available, and have few side effects. However, they require consistent and correct use to be effective, and may not protect against sexually transmitted infections (STIs). Fertility awareness-based methods involve tracking a woman's menstrual cycle and avoiding intercourse during the fertile window, when ovulation is most likely to occur. These methods include the calendar method, the basal body temperature method, and the cervical mucus method. They require careful monitoring and may not be as effective as other methods of contraception, particularly if a woman has irregular periods. Intrauterine devices (IUDs) are small, T-shaped devices that are inserted into the uterus by a healthcare provider. They can be either copper or hormone-free, and work by preventing fertilization or implantation of a fertilized egg in the uterus. They are highly effective and long-lasting, and do not require daily attention like other forms of contraception. However, they may cause discomfort during insertion and removal, and can increase the risk of pelvic inflammatory disease (PID).

US Non-Hormonal Contraception Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 27.1 billion

Largest Segment

Male

Fastest Growth

Male

Growth Rate

6.5% CAGR

Global Non-Hormonal Contraception Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
Global Non-Hormonal Contraception Market Size By Gender 2022-2030 ($ Bn)
Global Non-Hormonal Contraception Market Size By Gender 2022-2030 (%)

To get more reports on the above market click here to Buy The Report

Global Non-Hormonal Contraception Market Segmental Analysis

Global Non-Hormonal Contraception market is segmented by gender, product type, and distribution Channel. Based on gender, the Non-Hormonal Contraception Market can be segmented into male, and female. Based on product type, the Non-Hormonal Contraception Market can be segmented into condoms, diaphragms, cervical caps, spermicides, and contraceptive sponges. Based on distribution channel, the Non-Hormonal Contraception Market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. Based on region, the Non-Hormonal Contraception Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Non-Hormonal Contraception Market Analysis by Gender

By gender, the market can be segmented into male and female. The male segment of the non-hormonal contraceptives market is primarily driven by the widespread adoption of condoms as a safe and effective method of contraception. Male condoms are widely available and affordable, making them the preferred choice for many men around the world. The increasing awareness about sexually transmitted infections (STIs) and the need for protection during sexual activity has also contributed to the growth of the male non-hormonal contraceptives market. Companies operating in this segment are focusing on product innovation and improving the quality and reliability of condoms to attract more consumers. For example, some companies are offering textured or ultra-thin condoms to enhance pleasure and improve user experience.

The female segment of the non-hormonal contraceptives market is a relatively smaller market but is growing at a significant rate. Female non-hormonal contraceptives include products such as diaphragms, cervical caps, contraceptive sponges, and spermicides. These products offer women a safe and effective alternative to hormonal contraceptives such as birth control pills or hormonal IUDs. The increasing awareness about the side effects of hormonal contraceptives and the rising demand for natural and eco-friendly contraceptives have contributed to the growth of the female non-hormonal contraceptives market. Companies operating in this segment are focusing on product development and innovation to offer women a wider range of options. For example, some companies are developing reusable menstrual cups as an alternative to disposable products.

Non-Hormonal Contraception Market Analysis by Distribution Channel

By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. The retail pharmacies segment holds a significant share of the market, as they are easily accessible and offer a wide range of non-hormonal contraceptive products. Consumers prefer retail pharmacies due to the convenience of obtaining these products over the counter, without requiring a prescription. Additionally, retail pharmacies offer personalized assistance and counseling services to help consumers select the right contraceptive method for their needs.

Hospital pharmacies also play an important role in the distribution of non-hormonal contraceptives. Hospitals often prescribe and dispense contraceptives to patients during visits. Hospitals are also equipped with medical professionals who can provide counseling and guidance on the use of contraceptives.

The online pharmacies segment is expected to witness significant growth during the forecast period, owing to the rising trend of e-commerce and the convenience of purchasing products online. Online pharmacies offer a wide range of non-hormonal contraceptives at competitive prices, with doorstep delivery options. This segment also enables consumers to compare prices and reviews of different products before making a purchase.

Global Non-Hormonal Contraception Market By Gender, 2022 (%), 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Non-Hormonal Contraception Market Regional Insights

North America dominates the global non-hormonal contraception market, owing to the high awareness levels, favorable reimbursement policies, and the availability of advanced healthcare infrastructure in the region. The United States is the largest market in North America, due to the high demand for non-hormonal contraceptive products and the presence of major players in the region. In addition, the growing trend of delaying childbirth and the increasing preference for non-invasive and reversible contraceptive methods among women are expected to drive the market growth in North America. The rising incidences of sexually transmitted infections and the need for effective prevention methods are also contributing to the growth of the non-hormonal contraception market in the region. Furthermore, the increasing adoption of technological advancements in the development of non-hormonal contraceptive products is expected to create opportunities for market growth in the region. The availability of various non-hormonal contraceptive products such as condoms, cervical caps, and diaphragms in retail pharmacies and online channels is expected to further drive the market growth in North America.

Asia Pacific (APAC) is expected to be the fastest-growing region in the global non-hormonal contraception market due to the increasing population levels, rising awareness about contraception, and improving healthcare infrastructure. Additionally, the growing demand for alternative contraceptive methods that do not have hormonal side effects is expected to drive market growth in the region. China and India are the largest markets for non-hormonal contraceptives in the APAC region due to the high population levels and increasing awareness about family planning. The governments in these countries are also taking initiatives to promote family planning and provide access to affordable contraceptive methods, which is expected to further drive market growth. Japan, South Korea, and Australia are also significant markets in the APAC region due to the high awareness levels and advanced healthcare infrastructure. These countries have high per capita income levels, which enable consumers to afford non-hormonal contraceptive products. The increasing adoption of e-commerce and the growing trend of online pharmacies is also expected to drive market growth in the APAC region. Online pharmacies offer a wide range of non-hormonal contraceptive products at competitive prices, with doorstep delivery options, which is expected to increase their accessibility to consumers in remote areas.

Global Non-Hormonal Contraception Market By Geography, 2022-2030, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Non-Hormonal Contraception Market Dynamics

Non-Hormonal Contraception Market Drivers

Increasing Awareness about Contraception

  • The increasing awareness about contraception is a major driver of the global non-hormonal contraception market. With the growing trend of family planning and the need for effective and safe contraceptive methods, consumers are seeking out non-hormonal options. The availability of educational resources and counseling services has also contributed to the increasing awareness levels among consumers, as they become better informed about the different types of contraceptive methods available to them. This has led to a higher demand for non-hormonal contraceptives in the market, as consumers seek out products that are safe, effective, and suited to their individual needs. As a result, manufacturers are developing new and innovative non-hormonal contraceptive products to meet the growing demand.

Growing Preference for Non-Invasive and Reversible Contraceptive Methods

  • The growing preference for non-invasive and reversible contraceptive methods is a key driver of the global non-hormonal contraception market. Many women prefer non-hormonal contraceptive options due to the side effects associated with hormonal contraceptives. Non-hormonal methods, such as condoms, copper IUDs, and diaphragms, provide a safe and effective alternative that does not alter the body's natural hormone levels. These methods are also reversible, which allows women the flexibility to switch to different forms of contraception as their needs change. As a result, the demand for non-hormonal contraceptive methods is increasing, leading to the development of new products and growth in the non-hormonal contraception market.

Non-Hormonal Contraception Market Restraints

Limited Availability and Awareness in Developing Countries

  • The non-hormonal contraception market faces limited availability and awareness in developing countries, which hinders market growth. Developing countries have a lack of infrastructure and resources to provide access to non-hormonal contraceptive products. Additionally, cultural and religious beliefs also play a role in limiting the use and availability of contraceptives in some developing countries. This can result in unintended pregnancies and higher rates of sexually transmitted diseases, which can hinder the growth of the non-hormonal contraception market.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Non-Hormonal Contraception Market Competitive Landscape

Non-hormonal contraceptives are an effective way to prevent pregnancy without relying on hormones. Some popular options include barrier methods like condoms and diaphragms, as well as intrauterine devices (IUDs) and natural family planning methods. While condoms are widely available and offer protection against sexually transmitted infections, diaphragms require a prescription and must be used with a spermicide. IUDs are a long-term option that can last up to 10 years, but they also require a medical professional for insertion. Natural family planning methods involve tracking ovulation and abstaining from sex during the fertile window. Overall, the competitive landscape for non-hormonal contraceptives offers a variety of options for individuals seeking safe and effective birth control.

Non-Hormonal Contraception Market Top Player’s Company Profiles

  • Bayer AG
  • Merck & Co., Inc.
  • Allergan
  • Cooper Surgical Inc.
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Agile Therapeutics
  • Afaxys, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Church & Dwight Co., Inc.
  • The Population Council, Inc.
  • Ansell Ltd.
  • Medicines360
  • Mylan N.V.
  • Okamoto Industries Inc.
  • Reckitt Benckiser Group plc
  • V-Care Pharma Pvt. Ltd.
  • Fuji Latex Co., Ltd.
  • Veru Inc.

Non-Hormonal Contraception Market Recent Developments

  • In February 2023, the pharmaceutical company Evofem Biosciences announced the launch of its new contraceptive product, called Veru-111, in the US market. This product is a hormone-free, non-invasive vaginal gel that can be used up to one hour before intercourse, and it also provides protection against sexually transmitted infections.
  • In January 2022, the pharmaceutical company Merck announced that it has completed the acquisition of Pandion Therapeutics, a biotech company that is developing a non-hormonal contraceptive vaccine.
  • In October 2021, a study published in the New England Journal of Medicine reported that a new non-hormonal contraceptive method, called NES/EE, was found to be effective in preventing pregnancy in women. This contraceptive is a combination of two non-hormonal agents that work together to prevent pregnancy.

Global Non-Hormonal Contraception Key Market Trends

  • One key market trend in the global non-hormonal contraception market is the increasing demand for natural and organic contraceptive products. Consumers are becoming more aware of the potential side effects associated with hormonal contraception and are seeking alternatives that are free from synthetic hormones and chemicals. Natural and organic non-hormonal contraceptives, such as condoms and natural family planning methods, are gaining popularity as they are perceived to be safer and more eco-friendly. The trend towards natural and organic products is also being driven by the growing focus on sustainability and environmental consciousness.

Global Non-Hormonal Contraception Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global non-hormonal contraception market analysis, the market is driven by factors such as the increasing awareness of the potential side effects of hormonal contraceptives, the growing demand for natural and organic contraceptive products, and the rise in government initiatives to promote family planning. However, the market also faces some challenges, such as limited availability and awareness in developing countries and safety concerns associated with non-hormonal contraceptives. To address these challenges, companies in the market are investing in research and development to improve the safety and efficacy of non-hormonal contraceptive methods. They are also expanding their distribution channels and increasing their marketing efforts to improve access to non-hormonal contraceptive products, particularly in developing countries. Additionally, partnerships and collaborations between key market players are expected to drive market growth by facilitating the development of new and innovative non-hormonal contraceptive products.

Report Metric Details
Market size value in 2021 USD 27.1 billion
Market size value in 2030 USD 47.77 billion
Growth Rate 6.5%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Gender
    • Male and Female
  • Product type
    • Condoms, Diaphragms, Cervical Caps, Spermicides, and Contraceptive Sponges
  • Distribution channel
    • Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bayer AG
  • Merck & Co., Inc.
  • Allergan
  • Cooper Surgical Inc.
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Agile Therapeutics
  • Afaxys, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Church & Dwight Co., Inc.
  • The Population Council, Inc.
  • Ansell Ltd.
  • Medicines360
  • Mylan N.V.
  • Okamoto Industries Inc.
  • Reckitt Benckiser Group plc
  • V-Care Pharma Pvt. Ltd.
  • Fuji Latex Co., Ltd.
  • Veru Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Non-Hormonal Contraception Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Non-Hormonal Contraception Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Non-Hormonal Contraception Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Non-Hormonal Contraception Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Non-Hormonal Contraception Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Non-Hormonal Contraception Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Non-Hormonal Contraception Market size was valued at USD 27.1 billion in 2021 and is poised to grow from USD 28.86 billion in 2022 to USD 47.77 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

Non-hormonal contraceptives are an effective way to prevent pregnancy without relying on hormones. Some popular options include barrier methods like condoms and diaphragms, as well as intrauterine devices (IUDs) and natural family planning methods. While condoms are widely available and offer protection against sexually transmitted infections, diaphragms require a prescription and must be used with a spermicide. IUDs are a long-term option that can last up to 10 years, but they also require a medical professional for insertion. Natural family planning methods involve tracking ovulation and abstaining from sex during the fertile window. Overall, the competitive landscape for non-hormonal contraceptives offers a variety of options for individuals seeking safe and effective birth control. 'Bayer AG', 'Merck & Co., Inc.', 'Allergan', 'Cooper Surgical Inc.', 'Mayer Laboratories, Inc.', 'The Female Health Company', 'Agile Therapeutics', 'Afaxys, Inc.', 'Pfizer Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Church & Dwight Co., Inc.', 'The Population Council, Inc.', 'Ansell Ltd.', 'Medicines360', 'Mylan N.V.', 'Okamoto Industries Inc.', 'Reckitt Benckiser Group plc', 'V-Care Pharma Pvt. Ltd.', 'Fuji Latex Co., Ltd.', 'Veru Inc.'

The increasing awareness about contraception is a major driver of the global non-hormonal contraception market. With the growing trend of family planning and the need for effective and safe contraceptive methods, consumers are seeking out non-hormonal options. The availability of educational resources and counseling services has also contributed to the increasing awareness levels among consumers, as they become better informed about the different types of contraceptive methods available to them. This has led to a higher demand for non-hormonal contraceptives in the market, as consumers seek out products that are safe, effective, and suited to their individual needs. As a result, manufacturers are developing new and innovative non-hormonal contraceptive products to meet the growing demand.

One key market trend in the global non-hormonal contraception market is the increasing demand for natural and organic contraceptive products. Consumers are becoming more aware of the potential side effects associated with hormonal contraception and are seeking alternatives that are free from synthetic hormones and chemicals. Natural and organic non-hormonal contraceptives, such as condoms and natural family planning methods, are gaining popularity as they are perceived to be safer and more eco-friendly. The trend towards natural and organic products is also being driven by the growing focus on sustainability and environmental consciousness.

North America dominates the global non-hormonal contraception market, owing to the high awareness levels, favorable reimbursement policies, and the availability of advanced healthcare infrastructure in the region. The United States is the largest market in North America, due to the high demand for non-hormonal contraceptive products and the presence of major players in the region. In addition, the growing trend of delaying childbirth and the increasing preference for non-invasive and reversible contraceptive methods among women are expected to drive the market growth in North America. The rising incidences of sexually transmitted infections and the need for effective prevention methods are also contributing to the growth of the non-hormonal contraception market in the region. Furthermore, the increasing adoption of technological advancements in the development of non-hormonal contraceptive products is expected to create opportunities for market growth in the region. The availability of various non-hormonal contraceptive products such as condoms, cervical caps, and diaphragms in retail pharmacies and online channels is expected to further drive the market growth in North America.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Non-Hormonal Contraception Market

Product ID: SQMIG35D2065

$5,300
BUY NOW GET SAMPLE